Peer-reviewed insights on immune biomarkers, protein interactions, and cutting-edge detection methodologies.
Discover how bone marrow micrometastasis (BMM) predicts recurrence and poor survival in node-negative NSCLC patients, with meta-analysis data showing 73% increased mortality risk.